Skip to content


Next-generation ther­a­peu­tics based on human genetics and data science

First Investment: 2018

San Diego – based Empirico is a drug discovery company employing customized data models and algorithms, as well as a huge dataset of health information from millions of individuals, to uncover causal connections between genes, proteins, and clinical outcomes and find new genetically validated drug targets. The Empirico Precision Insights Platform helps the company’s scientists generate, interrogate, and prioritize hypotheses about the genetic variants behind health risks and possible ways to interfere with the mechanisms of disease.

Explore Companies